NCT02776098View on ClinicalTrials.gov

Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 4, 2024

Study Completion Date

March 4, 2024

Conditions
Cystic Fibrosis
Trial Locations (2)

19104

Children's Hospital of Philadelphia, Philadelphia

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Pennsylvania

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT02776098 - Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance | Biotech Hunter | Biotech Hunter